Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe

Related Content

What Sponsors Stand to Lose If Site Payment Infrastructure Doesn't Improve

ByPatrick Mizer,Andy Studna, Senior Editor

August 27th 2026

Generative AI is moving faster than any technology shift in history—and sponsors and CROs that treat a powerful model as a strategy, rather than a governed, validated workflow, are gambling with patient safety and regulatory standing.

AI Is Moving Faster Than Any Technology Before It

ByPhilip Raeth

August 27th 2026

ACT Brief: AI in Invoice Processing, Botanical Medicines and FDA Pathways, and Connected Trial Finance Systems

ByAndy Studna, Senior Editor

August 27th 2026

A survey of 300 clinical operations executives conducted last year by Frost & Sullivan and sponsored by IQVIA found that the manual effort required to connect siloed systems and processes is the top challenge in clinical trial financials. Credit: Stock.Adobe.com/photon_photo.

From Doing to Reviewing: How a Connected Ecosystem Streamlines Clinical Trial Finance

ByRajesh Patel,Zahiah (Zee Zee) Gueddar

August 26th 2026

Beyond Compliance: AJNA BioSciences' Joel Stanley on Bringing Botanical Medicine Through the FDA Pathway

ByOtis Johnson, PhD, MPA,Joel Stanley,Andy Studna, Senior Editor

August 26th 2026

ACT Cover

Articles in this issue

Related Content

What Sponsors Stand to Lose If Site Payment Infrastructure Doesn't Improve

AI Is Moving Faster Than Any Technology Before It

ACT Brief: AI in Invoice Processing, Botanical Medicines and FDA Pathways, and Connected Trial Finance Systems

From Doing to Reviewing: How a Connected Ecosystem Streamlines Clinical Trial Finance

Beyond Compliance: AJNA BioSciences' Joel Stanley on Bringing Botanical Medicine Through the FDA Pathway

Trending on Applied Clinical Trials Online

AI Is Moving Faster Than Any Technology Before It

Where AI Is Delivering Real Value in Clinical Trial Payments Right Now

ACT Brief: AI in Invoice Processing, Botanical Medicines and FDA Pathways, and Connected Trial Finance Systems

What Sponsors Stand to Lose If Site Payment Infrastructure Doesn't Improve

ACT Brief: Payment Infrastructure and Site Cash, Inspection Readiness Throughout Execution, and First Hemolytic Anemia Therapy